AF and SD-OCT useful in diagnosis of AIR

Article

Autofluorescence (AF) and spectral domain optical coherence tomography (SD-OCT) can detect structural abnormalities in patients with autoimmune retinopathy (AIR), according to a recent study.

Autofluorescence (AF) and spectral domain optical coherence tomography (SD-OCT) can detect structural abnormalities in patients with autoimmune retinopathy (AIR), according to a recent study.

Dr Prithvi Mruthyunjaya et al., Department of Ophthalmology, Duke Eye Centre, Durham, North Carolina, USA, completed a retrospective, observational case series of 14 eyes of seven patients wit AIR. The team collected colour fundus photographs, fundus AF images and SD-OCT at presentation.

Six patients had a history of cancer and were diagnosed with cancer-associated retinopathy or melanoma-associated retinopathy. Abnormalities, including loss of outer retinal layers, were found in six patients.

One patient presented with cancer-associated retinopathy and progressive loss of retinal structure, which was linked to the formation of a hyper-AF ring.

Based on the results, it was found that fundus AF and SD-OCT can detect structural abnormalities in patients with AIR. The areas of hyper-AF that correspond to loss of outer-retinal structures include the inner segment/outer segment junction, the external limiting membrane and outer nuclear layer.

To read more please visit the British Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.